Distinguishing neurosarcoidosis from multiple sclerosis based on cerebrospinal fluid analysis: A retrospective cohort study

Distinguishing neurosarcoidosis from multiple sclerosis based on cerebrospinal fluid analysis: A retrospective cohort study

Bibliographic Details
Main Authors:	Arun, T, Pattison, L, Palace, J
Format:	Conference item
Language:	English
Published:	BMJ 2019

Similar Items

Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study
by: Arun, T, et al.
Published: (2020)

Cerebrospinal fluid in multiple sclerosis
by: Rammohan Kottil
Published: (2009-01-01)

The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)

Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis
by: Keld-Erik Byg, et al.
Published: (2021-02-01)

Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
by: Bruna Lo Sasso, et al.
Published: (2019-06-01)

Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing–Remitting Multiple Sclerosis: A Retrospective Cohort Study
by: Xingwei Fang, et al.
Published: (2023-06-01)

Multiple sclerosis in Brazil: analysis of cerebrospinal fluid by standard methods
by: MARZIA PUCCIONI-SOHLER, et al.
Published: (1999-12-01)

Neurosarcoidosis
by: M. Yu. Maksimova
Published: (2017-02-01)

Neurosarcoidosis
by: Waldemar Brola, et al.
Published: (2014-04-01)

Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis
by: Ilaria Callegari, et al.
Published: (2023-01-01)

Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis
by: Ehling Rainer, et al.
Published: (2011-10-01)

Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis
by: Jonas Bergquist, et al.
Published: (2012-06-01)

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction
by: Benjamin Vlad, et al.
Published: (2023-03-01)

Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
by: Probert, F, et al.
Published: (2021)

The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis.
by: Moulin, D, et al.
Published: (1983)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
by: Ranjani Ganapathy Subramanian, et al.
Published: (2021-11-01)

Clinical spectrum and outcome of neurosarcoidosis: A retrospective cohort study from a teaching hospital in India
by: Arun Mathai Mani, et al.
Published: (2020-01-01)

ALKALINE ISOELECTRIC-FOCUSING IN POLYACRYLAMIDE-GEL OF CEREBROSPINAL-FLUID IN MULTIPLE-SCLEROSIS
by: Ebers, G, et al.
Published: (1979)

ANTIIDIOTYPIC SERA IN THE STUDY OF CEREBROSPINAL-FLUID IGG BANDS IN MULTIPLE-SCLEROSIS
by: Ebers, G
Published: (1979)

Alkaline isoelectric focusing in polyacrylamide gel of cerebrospinal fluid in multiple sclerosis.
by: Ebers, G, et al.
Published: (1979)

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
by: Franz Felix Konen, et al.
Published: (2022-07-01)

The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis
by: Gregory F. Wu, et al.
Published: (2023-04-01)

Adhesion molecules and proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients
by: S. A. Yelchaninova, et al.
Published: (2009-02-01)

Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?
by: Salvatore Monaco, et al.
Published: (2011-11-01)

IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
by: Mario Stampanoni Bassi, et al.
Published: (2020-06-01)

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers
by: Lorenzo Gaetani, et al.
Published: (2021-01-01)

Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
by: Timur Khaibullin, et al.
Published: (2017-05-01)

Brain MRI in patients with multiple sclerosis with oligoclonal cerebrospinal fluid bands
by: Mesaroš Šarlota, et al.
Published: (2003-01-01)

Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis
by: M.A. Moreira, et al.
Published: (2006-04-01)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
by: Agnieszka Kulczyńska-Przybik, et al.
Published: (2022-07-01)

Quantitative Analysis of Cerebrospinal Fluid Brain Derived Neurotrophic Factor in the Patients with Multiple Sclerosis
by: Farhad Mashayekhi, et al.
Published: (2012-01-01)

Cerebrospinal fluid cytotoxicity in lateral amyotrophic sclerosis
by: J. Matías-Guiu, et al.
Published: (2010-01-01)

Neurosarcoidosis, Coccidioidomycosis, or Both!
by: Akhavanrezayat A, et al.
Published: (2023-12-01)

Neurosarcoidosis manifesting as panhypopituitarism
by: Monique Oye, et al.
Published: (2019-12-01)

Neuropsychological diagnostics of neurosarcoidosis
by: Vera B. Nikishina, et al.
Published: (2018-02-01)

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
by: M. N. Olesen, et al.
Published: (2019-03-01)

Metabolomics of Cerebrospinal Fluid Amino and Fatty Acids in Early Stages of Multiple Sclerosis
by: Michal Židó, et al.
Published: (2023-11-01)

Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid
by: Enedina Maria Lobato de OLIVEIRA, et al.
Published: (2019-10-01)

Integration of small RNAs from plasma and cerebrospinal fluid for classification of multiple sclerosis
by: Maria Needhamsen, et al.
Published: (2022-11-01)

Flow volume measurement of arterial venous and cerebrospinal fluid in patients with multiple sclerosis
by: Serpil Aglamis, et al.
Published: (2022-07-01)